Cargando…

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767709/ https://www.ncbi.nlm.nih.gov/pubmed/31632460 http://dx.doi.org/10.1177/1756286419878321

Ejemplares similares

Neuromuscular Involvement in COVID-19 Patients
por: Finsterer, Josef
Publicado: (2021)

Imaging abnormalities in pediatric neuro-COVID are more diverse than specified
por: Finsterer, Josef
Publicado: (2022)

Advances in imaging of brain abnormalities in neuromuscular disease
por: Angelini, Corrado, et al.
Publicado: (2019)

The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad
por: Finsterer, Josef
Publicado: (2022)

Late-onset Pompe disease manifests in the brain
por: Finsterer, Josef
Publicado: (2019)

Psychiatric abnormalities in COVID-19 patients should prompt work-up for neuro-COVID
por: Finsterer, Josef
Publicado: (2023)

The Broad Spectrum of Neuro-Radiological Abnormalities in Patients Infected with SARS-CoV-2 Supports the Diagnosis of Neuro-COVID-19
por: Finsterer, Josef
Publicado: (2022)

Vision, brain, and nerves affected by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2023)

Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity
por: Stollberger, Claudia, et al.
Publicado: (2015)

Cerebral Magnetic Resonance Imaging Lesions in Leigh Syndrome are Variegated
por: Finsterer, Josef
Publicado: (2023)

No need for brain biopsy in acute disseminated encephalomyelitis after first Sputnik-V jab
por: Finsterer, Josef
Publicado: (2022)

Metabolomics by magnetic resonance spectroscopy may not sufficiently explain “brain fog” in neuro-COVID
por: Finsterer, Josef
Publicado: (2022)

In Reply to “The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad”
por: Imasawa, Toshiyuki, et al.
Publicado: (2022)

Reply to “Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?”
por: Ji, Wentao, et al.
Publicado: (2022)

Author reply to letter to the editor “Imaging abnormalities in pediatric neuro-COVID are more diverse than specified”
por: Mun-Ching Wong, Alex, et al.
Publicado: (2023)

Reply to: “Liver tests abnormalities in COVID-19: trick or treat?”
por: Cai, Qingxian, et al.
Publicado: (2020)

ATAD3A variants manifest multisystematically in the brain, nerves, eyes, heart, liver, and skin
por: Finsterer, Josef, et al.
Publicado: (2020)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Congenital nystagmus, disability, visual impairment, and noncompaction suggest hereditary disease
por: Finsterer, Josef
Publicado: (2019)

Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Paredes, Stephania, et al.
Publicado: (2023)

Dilative arteriopathy in Pompe disease may not only affect the cerebral arteries
por: Finsterer, Josef
Publicado: (2018)

Camptocormia due to myotinilopathy, Parkinson’s disease, or both?: Camptocormia and axial myopathy
por: Finsterer, Josef
Publicado: (2023)

Comments on: Neuro-ophthalmic presentation of COVID-19 disease: A case report
por: Finsterer, Josef
Publicado: (2021)

Fractal genetics and heterogeneous phenotypes of mitochondrial disease require appropriate logistics of managing network structures
por: Finsterer, Josef
Publicado: (2019)

Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG
por: Finsterer, Josef, et al.
Publicado: (2017)

Factors Influencing Central Nervous System Abnormalities in m.11778G>A Carriers
por: Finsterer, Josef
Publicado: (2020)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

Phenotype of NDUFV1-related Disease
por: Finsterer, Josef, et al.
Publicado: (2019)

Comment on “Symptomatic Trifascicular Block in Steinert's Disease: Is It Too Soon for a Pacemaker?”
por: Finsterer, Josef, et al.
Publicado: (2016)

Chemotherapy and quality of life in advanced NSCLC – reply
por: Anderson, Heather, et al.
Publicado: (2001)

Evaluating new treatments for advanced cancer – reply
por: Ferguson, Jamie
Publicado: (2001)

Reply to: The definition of locally advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2010)

Brain Magnetic Resonance Imaging Abnormalities in Patients with Hereditary Hemorrhagic Telangiectasia
por: Kobayashi, Zen
Publicado: (2021)

Carriers of POLG1 variants require investigations for multisystem disease and for mtDNA variations
por: Finsterer, Josef, et al.
Publicado: (2022)

Fatigue is part of the burden of neuromuscular diseases
por: Wokke, J. H. J.
Publicado: (2007)

Brain–Heart Interactions are More Diverse than Anticipated
por: Finsterer, Josef, et al.
Publicado: (2020)

Guillain–Barre syndrome with pleocytosis requires workup for cerebral disease
por: Finsterer, Josef, et al.
Publicado: (2023)

Suspicion of mitochondrial disease remains frequently unconfirmed after whole exome sequencing
por: Finsterer, Josef, et al.
Publicado: (2018)

In reply to the letter to the editor regarding “Cemented versus uncemented hemiarthroplasty for femoral neck fractures in patients with neuromuscular diseases: a minimum of 2 years’ follow-up study”
por: Wang, Yuchuan, et al.
Publicado: (2021)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_stf2ddplq8cemithodstaeiug0